About this event

  • Date and time Tue 11 Jul 2023 from 5:30pm to 6:30pm
  • Location Online

Hormone replacement therapy (HRT) and dementia - is there really a link?  

A recent study by researchers in Denmark concluded that menopausal hormone therapy and its involvement with the development of dementia. The publication of the study led to widespread media coverage and public discussion.

Join this one-hour webinar where experts in the field will explore the detail behind the recent news headlines, covering the new research paper, published in the BMJ, and what we already know in this area.

The panel of experts includes Dr Sarah Glynne, GP and menopause specialist, Dr Kejal Kantarci, Professor and researcher in neuroimaging, neuroscience, and clinical aspects of ageing, menopause and dementia, and Prof Pauline Maki, Director of the Women’s Mental Health Research Program at the UIC specialised in women's health and the effect of menopausal hormone therapy on cognition and mood. Professor Gillian Leng CBE, Dean of Education at the RSM, will be chairing the session.

Almost two million women in the UK are taking hormone replacement therapy, and this session will be of interest to all those involved in prescribing their treatment.  

*There may be slight changes to the advertised start and end times of this event, subject to the speakers' work requirements.

Follow us on:

Key speakers

Dr Sarah Glynne

Dr Sarah Glynne

General Practitioner Menopause Specialist, Miss Claire Mellon & Associates

Speaker's biography

Dr  Sarah Glynne graduated from Imperial College School of Medicine with Honours in 1999. She qualified as a member of the Royal College of Physicians in 2002, and the Royal College of General Practitioners in 2008. In 2016 she was awarded a Master of Science degree in immunology and allergy. 

Dr Glynne is a GP Menopause Specialist. In addition to her clinical practice, she holds an academic position at Newson Health where she contributes to research and education.

Dr Glynne is particularly interested in the link between Covid-19 and hormone imbalance. Hormonal perturbations are a major barrier to recovery in many female patients with long Covid, and hormone therapy (HRT) can significantly improve health and quality of life. She is also interested in the management of menopausal symptoms in women with a history of breast cancer. She is keen to promote access to evidence-based care for breast cancer survivors and support women to make informed decisions about their treatment options.  

Dr Kejal Kantarci

Dr Kejal Kantarci

Katherine B. Andersen Endowed Professor Director, Women’s Health Research Center Associate Director, Alzheimer’s Disease Research Center, Mayo Clinic Healthcare

Speaker's biography

Dr Kejal Kantarci is Katherine B. Andersen Endowed Professor in Women’s Health, and Professor of Radiology in the Division of Neuroradiology at Mayo Clinic Rochester. She is the Director of the Women’s Health Research Center, Associate Director of the Mayo Clinic Alzheimer’s Disease Research Center; and Principal Investigator of the Building Research Careers in Women’s Health (BIRCWH) K12 Program. Her research focuses on the neuroimaging, neuroscience and clinical aspects of aging and dementia, particularly in women’s cognitive health and Lewy body dementias.


Dr. Kantarci is a member of the Society of Women's Health Research Alzheimer 's Disease Network and member of the Dementia with Lewy Bodies Scientific Advisory Council.  Currently, she is leading an National Institutes of Health (NIH)-funded multi-center program on determining the long-term effects of early menopausal hormone therapy on Alzheimer’s pathophysiology (Overview - KEEPS Continuation Study - Mayo Clinic Research).


She received the Beeson award from the NIA/NIH in 2007, de Leon Prize in Neuroimaging Senior Scientist Award from the Alzheimer’s Association in 2018, was selected the Senior Fellow of the International Society of Magnetic Resonance in Medicine in 2021. Dr Kantarci Chaired the Alzheimer’s Association International Conference in 2019 and was the Co-chair NIH Alzheimer's Disease Related Dementias (ADRD) 2022 Summit on Lewy Body dementias. Dr Kantarci is a member of Leaders Empowering the Advancement of Diversity in Education, Research and Science (LEADERS) in the Health of Women. 

Professor Pauline Maki - High res

Professor Pauline Maki

Professor of Psychiatry, Psychology and Obstetrics and Gynaecology, University of Illinois, Chicago

Speaker's biography

Dr Pauline M Maki is Professor of Psychiatry, Psychology and Obstetrics and Gynecology; Director of the Women’s Mental Health Research Program, and Associate Dean for Faculty Affairs at the University of Illinois at Chicago (UIC). For the past 25 years, she has led a program of research on women’s health, particularly women’s mental and cognitive health. She has over 200 scientific publications on this topic. Her research addresses important issues in women’s health such as how hormonal changes and menopause symptoms affect women’s cognition, brain function and mood at midlife and the effect of menopausal hormone therapy on cognition and mood.


Dr Maki is Past President of the North American Menopause Society (NAMS), Treasurer of the International Menopause Society, and past Chair of the Society for Women’s Health Research Interdisciplinary Network on Alzheimer’s Disease. She won the 2018 Woman in Science Award from the American Medical Women’s Association, the Thomas B. Clarkson Outstanding Clinical and Basic Science Research Award from the NAMS, and the 2023 Health Education Visionary Award from the Society for Women’s Health Research. She has won several National Institutes of Health (NIH) awards for her research and service, serves as a research and career mentor to many students and junior faculty, serves on executive committees for several women’s health advisory boards, and is a frequent international and national speaker.


Her work is widely cited in the media, including in such outlets as the New York Times, Wall Street Journal, Washington Post, Fox News, National Public Radio, BBC, Woman’s Hour, the Today Show, NBC News, ABC News, and the Guardian. Her work on mental health in pregnancy and the postpartum has received accolades from the Kennedy Forum, the news media, and the Office of the Vice President of the United States.




Registration for this event will close on 11 July 2023 at 5:00pm. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Free webinars - promo

Watch your next webinar for free as an RSM member

RSM members have free access to over 100 hours of educational webinars each year. 

Become a member